Sai Parenterals Acquires 60% Stake in Prathyak Laboratories for Rs 15 Crore
Sai Parenterals Ltd 路 Press Release 路 05 Oct 2026, 9:12 pm
Sai Parenterals Acquires 60% Stake in Prathyak Laboratories for Rs 15 Crore On 5th Oct'26, Sai Parenterals completed the acquisition of a 60% equity stake in Hyderabad-based R&D center Prathyak Laboratories for Rs. 15 crore, funded via unutilized IPO proceeds. The acquisition replaces its planned greenfield R&D facility, adding 28 scientists and a pipeline of 150 SKUs across 86 molecules in complex and oncology injectables. Sai Parenterals holds a Right of First Refusal to acquire the remaining 40% at the same valuation via internal accruals, strengthening its regulated-market injectable franchise and Australia-New Zealand supply commitments.
Original exchange filing (PDF)
More announcements from Sai Parenterals Ltd
- Press Release by Sai Parenteral''s Limited 路 17 Nov 2026
- Outcome of Board Meeting held on Monday, 16th November, 2026 路 17 Nov 2026
- call conducted on Monday the 2nd day of November, 2026. 路 07 Nov 2026
- Audio recording of earning call held on 2nd November, 2026 over call. 路 03 Nov 2026
- Investor Presentation for the quarter and half year ended 30th September, 2026 路 02 Nov 2026
- Investor press release on standalone and consolidated unaudited financial results for the quarter ended 30th September, 2026. 路 01 Nov 2026
- Statement of variation and deviation for the period ended 30th September, 2026 路 01 Nov 2026
- Financial Results 路 01 Nov 2026
